Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: SynAct comments on positive Phase II data

Yesterday, preliminary data from SynAct Pharma’s Phase II study with the drug candidate AP1189 in patients with rheumatoid arthritis was released. The data indicate that AP1189, administered in doses of 50 mg, is safe and well-tolerated. The blinded review of the data also indicates a substantial reduction in disease severity among two thirds of the patients, which may be attributed to AP1189. BioStock reached out to the company’s CEO Jeppe Øvlesen for a comment on the positive indicative results.Read the full interview with Synact Pharma's CEO Jeppe Øvlesen at biostock.se: https://www.

Caverion Corporation will redeem its outstanding hybrid notes

Caverion Corporation Stock exchange release 6 May 2020 at 1:00 p.m. (EEST)Caverion Corporation will redeem its outstanding hybrid notes Caverion Corporation (“Caverion” or the “Company”) announces that it will exercise its right to redeem its remaining EUR 66.06 million hybrid notes (the “2017 Capital Securities”) issued on 16 June 2017 (ISIN: FI4000266614). The outstanding EUR 66.06 million 2017 Capital Securities will be redeemed in full on 16 June 2020 (the “Redemption Date”) in accordance with its terms and conditions. On the Redemption Date, Caverion will pay the holders of the

Annual General Meeting of Byggmax Group AB (publ)

The Annual General Meeting of Byggmax Group AB (publ) took place on Wednesday, May 6, 2020 in Stockholm, Sweden. The Annual General Meeting resolved in line with all of the motions presented in the notification of the AGM. Resolution regarding adoption of the income statement and balance sheet etc. The AGM resolved to adopt the income statement and balance sheet for the Parent Company as well as the consolidated income statement and consolidated balance sheet for 2019. The Board of Directors and the Managing Director were discharged from liability for the 2019 fiscal year.

DexTech Medical AB Interim report July 1, 2019 - March 31, 2020

Summary of the Nine-Month period (2019-07-01 - 2020-03-31) • Net sales amounted to MSEK 0,0 (0,0) • Operating profit/loss amounted to MSEK -5,8 (-6,2) • Earnings per share * SEK -0.39 (-0.42) • Cash and cash equivalents at the end of the period amounted to MSEK 6,6 (0,0) * Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 14,909,545 For the comparison period, the average number of shares was 14,752,833. Amounts in brackets refer to the corresponding period last year. Summary of the Third Quarter (January 1 - March

East Capital Holding completes its acquisition of Adrigo Asset Management

East Capital Holding has completed the previously announced acquisition of Adrigo Asset Management. Adrigo becomes the absolute return and specialised strategies platform of the East Capital Group, sitting alongside the East Capital, East Capital Real Estate and Espiria families of funds.Adrigo Asset Management currently manages approximately EUR 50m of assets in two award-winning hedge fund strategies, Adrigo Hedge and Adrigo Small & Mid Cap L/S. The fund managers of Adrigo Small & Mid Cap L/S have remained with the company and will continue to manage the funds going forward. East Capital

FIRST QUARTER OF 2020

· Rental revenue increased 13% to SEK 703 M (622 for the preceding year). · Profit from property management increased 22% to SEK 565 M (464). · Profit from property management per Class A and B share after dilution rose 23% to SEK 1.57 (1.28). · Revaluation of properties and financial instruments impacted profit by a total of SEK 166 M (478). · Profit after tax for the period amounted to SEK 749 M (854). · Cash flow from operating activities before changes in working capital rose 29% to SEK 416 M (323), corresponding to SEK 1.11 (0.83) per Class A and B share after dilution.

BioStock: New partnership adds support to development of Iconovo’s Symbicort generic

The Lund-based inhaler experts Iconovo are on the front lines of the fight against asthma, and they recently announced a new partnership dedicated to the development of ICOres budesonide/formoterol, the generic for AstraZeneca’s Symbicort, which is currently on the market for the treatment of asthma. BioStock was able to talk with Iconovo’s CEO Johan Wäborg to discuss the implications of the partnership and what it means for the ongoing battle against asthma.Read the full interview with Johan Wäborg at biostock.se: https://www.biostock.se/en/new-partnership-adds-support-to-development-of-

CEO´s presentation on today´s Annual General Meeting of Shareholders is now available.

The presentation can be found on our website www.arise.se Halmstad 6 May, 2020ARISE AB (publ)   For further information, please contactDaniel Johansson, CEO Arise AB, +46 702 244 133Linus Hägg, CFO Arise AB, +46 702 448 916 This information is information that Arise AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, at 11.00 CET on 6 May, 2020. Regarding information about how we process your personal data we refer to our Privacy policy, which is available on our website www.arise.se. If you no longer wish

NRC Group ASA - Annual General Meeting held

The Annual General Meeting of NRC Group ASA (the “Company”) was held today 6 May 2020. All resolutions were passed in accordance with the proposals set out in the notice for the Annual General Meeting. The minutes of the Annual General Meeting are attached and are also available on the Company’s website. For further information, please contact: CFO Dag Fladby, telephone: +47 90 89 19 35. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Notice of Ordinary General Meeting of poLight ASA

The shareholders of poLight ASA are herby summoned to the Ordinary General Meeting on Thursday 28 May, 2020 at 12.30 hours, at Kongeveien 77, Horten. Please find attached the notice of the Ordinary General Meeting together with the statement regarding the determination of salaries and other compensation to the management and recommendation by the nomination committee, and the attendance & proxy forms. The Annual Report 2019 was published 23 April, 2020, and is available on the company's web site. The Notice and attendance & proxy forms will be posted electronically or by mail to all

Invitation to presentation of Eastnine’s Interim report January‒March 2020

Eastnine's Interim report January–March 2020 will be published on Tuesday, 12 May 2020 at 8 a.m. CET. The report will be presented at a telephone conference the same day by Kestutis Sasnauskas, CEO at Eastnine and Britt-Marie Nyman, CFO and deputy CEO. Date:                                               Tuesday, 12 May 2020 Time:                                               10 a.m. CET Dial-in numbers:                              +46 8 566 427 05 (SE)                                                         +1 833 526 83 97 (US)                      +44 333 300 92 69 (UK)

Bublar Group wins MedTech company Rimasys as new client for 3D and AR in surgical education

Bublar Group’s subsidiary Sayduck will help Germany-based Rimasys to show how its mobile surgical training lab works without visiting the lab physically. This is another innovative example of how to utilize the SaaS-platform for 3D and AR. More and more industries are starting to see the real benefits and usability of XR-technology. Rimasys represents a different approach with its surgical training. Rimasys will utilise 3D and AR to show off its mobile labs that are possible to rent for surgical training. The labs can in the initial phase virtually be taken to hospitals and conferences

Valmet chosen by EPC Hitachi Zosen Inova AG to deliver automation for greenfield waste-to-energy plant in Moscow, Russia

Valmet will supply automation to a new waste-to-energy facility in Moscow, Russia [Valmet chosen by EPC Hitachi Zosen Inova AG to deliver automation for greenfield waste-to-energy plant in Moscow, Russia] Valmet chosen by EPC Hitachi Zosen Inova AG to deliver automation for greenfield waste-to-energy plant in Moscow, Russia Valmet Oyj’s trade press release on May 6, 2020 at 11:00 a.m. EET Valmet will supply automation to a new waste-to-energy facility in Moscow, Russia. The order was placed by Hitachi Zosen Inova AG (HZI), the engineering, procurement and construction contractor

Brighter receives SEK 9,2 million through exercise of warrants

The final exercise period for Brighter’s warrants of series TO3 is now completed. The company thereby receives approximately SEK 9.2 million. The number of shares increases by 4 592 991, to a total of 199 036 580 shares. Brighter TO3 now ceases to exist. Those who subscribed in this exercise period have now obtained interim shares. Once the registration has been completed with the Swedish Companies Registration Office, conversion of the interim shares will automatically take place without further notice to the holders. For further information, please contact: Ann Zetterberg, CFO

Extended utilization of transfer authorization in Investor AB

The Annual General Meeting of Investor 2019 decided to authorize the company’s Board to decide on the transfer of the company’s own shares in order to, among other things, secure costs for Investor’s long-term variable remuneration program for employees within Investor and for the issue of synthetic shares as part of the Board remuneration.  As previously communicated, the company’s Board has decided to utilize the authorization for these purposes. Due to the postponed Annual General Meeting the transfer period is extended to the Annual General Meeting on June 17, 2020. The transfer

Insr: Notice of Annual General Meeting May 20th, 2020

The Board of Directors of Insr Insurance Group ASA hereby convenes an Ordinary General Meeting. Time: 20 May 2020 at 14:00 (CET)Place: Insr's offices in Østensjøveien 43, 0667 Oslo.Due to Covid-19, and all shareholders are requested to attend by proxy and only the ones who have returned the attendance slip within the deadline will be able to attend the meeting. Please find more information in the attached document.For more information, please contactAnne B. KnudtzonSVP Business Controlling & Investor RelationsPhone: +47 926 10 606E-mail: anne.b.knudtzon@insr.io

YIT Corporation: Managers’ transactions – Tuomela

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:14 a.m.YIT Corporation: Managers’ transactions – Tuomela YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Tuomela, Tiina Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_48 _____

YIT Corporation: Managers’ transactions – Topolska

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:12 a.m.YIT Corporation: Managers’ transactions – Topolska YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Topolska, Barbara Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_51 _

YIT Corporation: Managers’ transactions – Pentti-von Walzel

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:10 a.mYIT Corporation: Managers’ transactions – Pentti-von Walzel YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Pentti-von Walzel, Kristina Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_

YIT Corporation: Managers’ transactions – Lehtinen

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:08 a.mYIT Corporation: Managers’ transactions – Lehtinen YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Lehtinen, Olli-Petteri Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_47

YIT Corporation: Managers’ transactions – Hyldmar

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:06 a.m.YIT Corporation: Managers’ transactions – Hyldmar YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Hyldmar, Frank Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_50 _____

Polygon appoints a new Director of International Sales

Polygon announced today the appointment of a new Director of International Sales – Hans Christian Sorensen.In recent years, Polygon has strengthened its international customer base. Many international customers appreciate that Polygon can deliver services in several countries.  To further strengthen our international presence and offer high quality services to our customer, the company has decided to appoint an International Sales Director who will focus on engaging the clients as well as to coordinate our sales and marketing efforts across boundaries. Hans-Christian has strong experience

Nixu Corporation Initiates a Cost Reduction Program to Address the Impact of the COVID-19

Nixu Corporation, Press release on May 6, 2020 at 10:05 AM EESTNixu Corporation estimates that the COVID-19 pandemic will lead to a situation where economic growth pace will slow sharply in 2020 and the economic impact will continue still in 2021. Although digitalization will progress strongly and the need for cybersecurity will only increase after the pandemic, Nixu estimates that its growth opportunities will be limited in the short term. For this reason, Nixu has decided in the short term to cut down on growth investments aimed at bringing very strong growth (during past years averaging

YIT Corporation: Managers’ transactions – Ehrnrooth

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:04 a.m.YIT Corporation: Managers’ transactions – Ehrnrooth YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Ehrnrooth, Alexander Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_49

There are no items matching the current filter
There are no more items matching the current filter
Back to top